TLR4 and heart disorder: However, the improvement or treatment of cardiac diseases with TLR4 inhibitors to date have not been launched in clinical trials, possibly because TLR4 inhibitors such as TAK-242 and eritoran have shown inadequate efficacy in other systems or organs.